5/20/2024China Set to Ease Controls on Genetic Resources to Plug Biotech Innova...

5/20/2024Sol-Gel and Beimei Pharma Strike Deal to Commercialize TWYNEO in Great...

5/20/2024NHSA Issues New Policy to Expand and Improve Centralized VBP for Drugs...

5/17/2024China's Healthcare Reform: Opening Doors to Foreign Investment in Hosp...

5/17/2024Mainland China and Macao Seek to Boost Healthcare Integration

5/17/2024Performance Review of A Share-Listed Chinese MedPharm Cos in 2023

5/17/2024Recent Executive Moves

5/17/2024Pharma Facing Growing Risks From Geopolitics, Industry Leaders Warn (S...

5/16/2024A Snapshot of Key Events in China This Week (AmCham China Newsletter /...

5/16/2024CDE Issues the Technical Guidelines for R&D of TCM Improvement Drugs

5/15/2024Eisai to Launch Alzheimer's Drug in China

5/15/2024China Biotech Podcast: BIOSECURE Markup, Biotech Pipeline Updates (Scr...

5/15/2024Chinese Biotech Crackdown Would Reset U.S. Drug Development (Axios)

5/15/2024China Biopharma Tracker – April 2024 (PharmaDJ)

5/14/2024A New Roud of National BMI Unannounced Inspection Initiated

5/14/2024NHC Issues the Standard for Drug Use Monitoring and Management in Publ...

5/10/2024China nears 2030 Health Literacy Goal with Major Advances in Public He...

5/10/2024NMPA Issues Doc on Domestic Production Transfer of Overseas-Produced D...

5/10/2024NHC Issues the Opinions on Strengthening Critical Care Medical Service...

5/10/2024NMPA Restores Import, Sales and Use of Celgene's Paclitaxel for Inject...

5/10/2024Recent Executive Movements

5/10/2024House's Updated Biosecurity Bill Sets 2032 Decoupling Deadline for Ind...

5/9/2024BIO Survey Shows 79% of US biotech Cos Contract with Chinese Firms

5/8/2024China Makes Progress in Enhancing Primary Healthcare Services

5/8/2024NHC Issues New Guidelines to Improve Critical Care Medical Services

5/8/2024China Moves to Improve Healthcare Experience of Patients: NHC

5/7/2024China's New Guidelines Boost Critical Care Services

5/7/2024Recent Executive Moves

5/7/2024Review of Leading Listed Chinese Pharma Cos by R&D Spending in 2023

5/7/2024Sanofi Saw 6.2% China Revenue Growth in Q1/2024 on Strong Drug Sales

Page:39/367 Total number of articles:10998: [First][<<] [37] [38] [39] [40] [41] [>>] [End]